ZD4054 (Zibotentan)

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Advanced Solid MalignanciesProstate Cancer

Phase 1

Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC

CompletedNCT00314782

AstraZenecaProstate Cancer

Start: 2006-03-31End: 2009-03-31Updated: 2013-03-12

10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies

CompletedNCT00997945

AstraZenecaAdvanced Solid Malignancies

Start: 2009-10-31End: 2011-04-30Updated: 2011-05-19